Cargando…
Mechanism of action of PD‐1 receptor/ligand targeted cancer immunotherapy [Image: see text]
Immunotherapy targeting the Programmed Death (PD‐1) receptor/ligand (L) “checkpoint” rapidly gains ground in the treatment of many cancer types. To increase treatment scope and efficacy, predictive biomarkers and rational selection of co‐treatments are required. To meet these demands, we must unders...
Autores principales: | Borst, Jannie, Busselaar, Julia, Bosma, Douwe M. T., Ossendorp, Ferry |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8453912/ https://www.ncbi.nlm.nih.gov/pubmed/34106465 http://dx.doi.org/10.1002/eji.202048994 |
Ejemplares similares
-
Human NK cells, their receptors and function [Image: see text]
por: Quatrini, Linda, et al.
Publicado: (2021) -
Multiomics uncovers developing immunological lineages in human [Image: see text]
por: Stephenson, Emily, et al.
Publicado: (2021) -
Non‐zero‐sum microbiome immune system interactions [Image: see text]
por: Tuganbaev, Timur, et al.
Publicado: (2021) -
Helpless Priming Sends CD8(+) T Cells on the Road to Exhaustion
por: Busselaar, Julia, et al.
Publicado: (2020) -
Subcorneal pustular dermatosis: Comprehensive review and report of a case presenting during pregnancy [Image: see text] ()()()
por: Bhargava, Shashank, et al.
Publicado: (2020)